Global Kidney Stones Therapeutic Market 2025-2029

Kidney Stones Therapeutic Market 2025-2029

The kidney stones therapeutic market is forecasted to grow by USD 582.9 mn during 2024-2029, accelerating at a CAGR of 5.1% during the forecast period. The report on the kidney stones therapeutic market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing popularity of flexible digital ureteroscopes, rising incidence of urolithiasis among global population, and increasing prevalence of kidney stone disease.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's kidney stones therapeutic market is segmented as below:

By End-user

• Hospitals
• Specialty clinics
• Ambulatory surgical centers

By Type

• Ureteroscopy
• Lithotripsy
• Percutaneous nephrolithonomy (PCNL)

By Therapy Area

• Calcium oxalate stones
• Uric acid
• Struvite kidney stones
• Cystine stones
• Calcium phosphate stones

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advances in technologies in kidney stones treatment as one of the prime reasons driving the kidney stones therapeutic market growth during the next few years. Also, rising geriatric population and initiatives to increase public awareness, physician education, and clinical training will lead to sizable demand in the market.

The report on the kidney stones therapeutic market covers the following areas:

• Kidney Stones Therapeutic Market sizing
• Kidney Stones Therapeutic Market forecast
• Kidney Stones Therapeutic Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading kidney stones therapeutic market vendors that include Anvik Biotech, Aristo Pharma GmbH, Bausch Health Companies Inc., Bayer AG, Biomedix Siomond Pharma, Cipla Inc., Cmg Biotech Pvt. Ltd., Dr Reddys Laboratories Ltd., Emcure Pharmaceuticals Ltd., GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson Services Inc., Macleods Pharmaceuticals Ltd., Medinova Diagnostic Services Ltd., Mission Pharmacal Co., Nostrum Pharmaceuticals LLC, Pfizer Inc., Walter Bushnell, Windlas Biotech Pvt. Ltd., and Worth Medicines Pvt. Ltd.. Also, the kidney stones therapeutic market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.